AMPH Q1 2019 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$80M+36.6% YoY

Gross Profit

$31M38.7% margin

Operating Income

-$3M-4.0% margin

Net Income

$868,0001.1% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

-11.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$545M

Total Liabilities

$164M

Stockholders' Equity

$335M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$58M	+36.6%
Gross Profit	$31M	$17M	+81.1%
Operating Income	-$3M	-$10M	+68.0%
Net Income	$868,000	-$7M	+112.0%

Revenue Segments

Active Pharmaceutical Ingredient Segment

$5M100%

Geographic Segments

U

$76M100%